Liu; Dingjiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Dingjiang.The latest application filed is for "characterization of impurities in adeno-associated virus (aav) samples and formulation compositions to stabilize aav".

Company Profile

9.10.20

Liu; Dingjiang - Pleasantville NY
Liu; Dingjiang - Oak Park CA
LIU; Dingjiang - Tarrytown NY
Liu; Dingjiang - Edison NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for quantitating individual antibodies from a mixture Grant 11,369,896 - Liu , et al. June 28, 2	2022-06-28
Characterization Of Impurities In Adeno-associated Virus (aav) Samples And Formulation Compositions To Stabilize Aav App 20220136073 - Jiang; Bowen ; et al.	2022-05-05
Characterization Of Adeno-associated Virus Using Microchip Capillary Electrophoresis App 20220065868 - Jiang; Bowen ; et al.	2022-03-03
Methods For Quantitating Individual Antibodies From A Mixture App 20210268404 - LIU; Dingjiang ; et al.	2021-09-02
Stable Antibody Formulation App 20210252146 - Cao; Yuan ; et al.	2021-08-19
Methods for quantitating individual antibodies from a mixture Grant 11,020,686 - Liu , et al. June 1, 2	2021-06-01
Formulation Optimization For Bispecific Antibodies App 20210054050 - Zhou; Chen ; et al.	2021-02-25
Methods For Quantitating Individual Antibodies From A Mixture App 20210031123 - LIU; Dingjiang ; et al.	2021-02-04
Method Of Treating Diseases Using An Il-17 Receptor Antibody Formulation App 20200399384 - Liu; Dingjiang ; et al.	2020-12-24
Stabilized Formulations Containing Anti-angptl3 Antibodies App 20200369760 - LIU; Dingjiang ; et al.	2020-11-26
IL-17 receptor antibody formulation Grant 10,808,033 - Liu , et al. October 20, 2	2020-10-20
Stabilized Formulations Containing Anti-IL-33 Antibodies App 20200297845 - Hu; Qingyan ; et al.	2020-09-24
Methods For Quantitating Individual Antibodies From A Mixture App 20190184312 - LIU; Dingjiang ; et al.	2019-06-20
Stable Antibody Formulation App 20190040137 - HU; Qingyan ; et al.	2019-02-07
Lyophilized therapeutic peptibody formulations Grant 10,166,189 - Callahan , et al. J	2019-01-01
Method Of Treating Psoriasis Using An Il-17 Receptor Antibody Formulation App 20180346583 - Liu; Dingjiang ; et al.	2018-12-06
Method of treating psoriasis using an IL-17 receptor antibody formulation Grant 10,072,085 - Liu , et al. September 11, 2	2018-09-11
Lyophilized Therapeutic Peptibody Formulations App 20160143852 - CALLAHAN; William J. ; et al.	2016-05-26
Lyophilized therapeutic peptibody formulations Grant 9,283,260 - Callahan , et al. March 15, 2	2016-03-15
IL-17 Receptor Antibody Formulation App 20150017184 - Liu; Dingjiang ; et al.	2015-01-15
IL-17 receptor antibody formulation Grant 8,883,151 - Liu , et al. November 11, 2	2014-11-11
Reducing Viscosity Of Pharmaceutical Formulations App 20130171128 - Huang; Holly Zhuohong ; et al.	2013-07-04
Antibody Formulation And Therapeutic Regimens App 20130022621 - Liu; Dingjiang ; et al.	2013-01-24
Lyophilized therapeutic peptibody Formulations App 20090258017 - Callahan; William J. ; et al.	2009-10-15
Hepatitis C virus NS3 helicase subdomain I Grant 7,459,296 - Weber , et al. December 2, 2	2008-12-02
Hepatitis C virus NS3 helicase fragments App 20040253577 - Weber, Patricia C. ; et al.	2004-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.